Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Incyte (INCY) Depreciation & Amortization (CF) (2010 - 2026)

Incyte's (INCY) quarterly Depreciation & Amortization (CF) came in at $26.5 million in Q2 2026, up 15.52% YoY from $22.9 million in Q2 2025, and up 11.23% on a QoQ basis from $23.8 million in Q1 2026.

Analysis

Incyte (INCY) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $26.5 million in Q2 2026.

  • Quarterly Depreciation & Amortization (CF) rose 15.52% year-over-year to $26.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $98.3 million (up 8.56% YoY) and the FY2025 annual result came in at $93.3 million, up 4.52% from the prior year.
  • Depreciation & Amortization (CF) grew to $26.5 million in Q2 2026, from $23.8 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $26.5 million in Q2 2026 to a low of $16.4 million in Q1 2022.
  • A 5-year average of $21.3 million and a median of $22.0 million in 2024 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) advanced 28.15% — and 2025, when it advanced 1.89%.
  • Tracing INCY's Depreciation & Amortization (CF) over 5 years: stood at $18.2 million in 2022, then gained by 19.45% to $21.8 million in 2023, then rose by 4.46% to $22.7 million in 2024, then grew by 5.49% to $24.0 million in 2025, then increased by 10.4% to $26.5 million in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $26.5 million (Q2 2026), $23.8 million (Q1 2026), and $24.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 40.52 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn 26.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.48 Mn
Mar 31, 2026 23.80 Mn
Dec 31, 2025 23.98 Mn
Sep 30, 2025 24.02 Mn
Jun 30, 2025 22.92 Mn
Mar 31, 2025 22.36 Mn
Dec 31, 2024 22.73 Mn
Sep 30, 2024 22.52 Mn
Jun 30, 2024 22.05 Mn
Mar 31, 2024 21.95 Mn
Dec 31, 2023 21.76 Mn
Sep 30, 2023 21.39 Mn
Jun 30, 2023 20.30 Mn
Mar 31, 2023 19.21 Mn
Dec 31, 2022 18.22 Mn
Sep 30, 2022 16.69 Mn
Jun 30, 2022 16.51 Mn
Mar 31, 2022 16.44 Mn
Dec 31, 2021 14.86 Mn
Sep 30, 2021 14.69 Mn